Find uplifting stories about heroes, innovations, and solutions
912 results for "** hpv vaccine"
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Scientists have designed a cancer vaccine that successfully fought HPV-related throat tumors in mice, offering hope for people battling these aggressive cancers. The breakthrough lies in how the vaccine's components are arranged, making it more effective at training the immune system to recognize and destroy cancer cells.
A landmark study shows South Africa's free school vaccination program slashed HPV infections by 83%, proving the vaccine works even in regions with high HIV rates. For the first time, researchers confirmed that early vaccination protects girls living with HIV just as well as those without it.
A groundbreaking 18-year study from Sweden shows the HPV vaccine provides lasting protection against cervical cancer, with no signs of weakening over time. Nearly a million women participated in research that could help eliminate cervical cancer as a public health threat.
Nigeria's Jigawa State is protecting girls from cervical cancer with free HPV vaccines, a move that could save thousands of lives. Health officials are reassuring parents the vaccine is safe and used worldwide.
Scientists have developed a therapeutic vaccine that successfully fought HPV-related cancers in mice, offering hope for patients with advanced disease. Unlike current vaccines that only prevent infection, this treatment targets existing tumors.
Young women vaccinated against HPV at age 12-13 now have close to zero risk of dying from cervical cancer before 30. A landmark study from England shows the vaccine has already saved around 200 lives since 2008.
For the first time ever, zero women aged 20-24 died from cervical cancer in the UK over a five-year period, thanks to routine HPV vaccination. Without the vaccine, 23 deaths would have been expected during that time.
Young women who get the HPV vaccine in their early teens have virtually no risk of dying from cervical cancer before age 30. This groundbreaking research proves the vaccine is even more life-saving than scientists initially believed.
India is rolling out a nationwide HPV vaccination campaign starting February 28 to protect 14-year-old girls from cervical cancer, which kills 75,000 Indian women every year. The free vaccine will be available at 30,000 centers across the country.
For the first time ever, no women aged 20 to 24 died from cervical cancer in England over a five-year period. The HPV vaccine given to schoolgirls since 2008 has saved around 200 lives and given vaccinated children "close to zero" risk of dying from the disease before age 30.
Panama became the first country in Latin America to offer universal HPV vaccination, and it's working. Cervical cancer rates have been steadily falling since the program launched, with vaccine coverage now exceeding 85 percent.
Nigeria is embedding the HPV vaccine into routine school health programs to prevent cervical cancer, one of the most preventable yet deadliest cancers for women. Early efforts show promise, but scaling up could save thousands of lives.
Breakthrough vaccines and treatments are dramatically reducing HPV-related cancers that affect millions worldwide. Scientists now have powerful new tools to prevent and treat cervical, throat, and other cancers caused by the virus.
A groundbreaking study of 1.7 million Americans reveals that HPV vaccination slashes head and neck cancer rates by more than half in men. As smoking declines but these cancers rise, scientists have found the solution hiding in plain sight.
After surviving cervical cancer through expensive treatment abroad, Irakoze Gratia celebrates as Burundi launches free HPV vaccines for girls. The preventable disease kills over 1,000 Burundian women each year.
Namibia just added the lifesaving HPV vaccine to its free public health program, protecting girls from cervical cancer. Health officials are fighting misinformation while celebrating this major step toward eliminating a disease that kills too many African women.
Women who received the HPV vaccine need far fewer cervical cancer screenings than current guidelines suggest, potentially just two or three times in their entire lives. This breakthrough could save millions of women from unnecessary medical procedures while maintaining the same health protection.
Showing 20 of 912